BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 11398085)

  • 1. Mechanisms of autoimmune activation of basophils in chronic urticaria.
    Kikuchi Y; Kaplan AP
    J Allergy Clin Immunol; 2001 Jun; 107(6):1056-62. PubMed ID: 11398085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria.
    Soundararajan S; Kikuchi Y; Joseph K; Kaplan AP
    J Allergy Clin Immunol; 2005 Apr; 115(4):815-21. PubMed ID: 15806004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basophil CD63 expression assay on highly sensitized atopic donor leucocytes-a useful method in chronic autoimmune urticaria.
    Gyimesi E; Sipka S; Dankó K; Kiss E; Hídvégi B; Gál M; Hunyadi J; Irinyi B; Szegedi A
    Br J Dermatol; 2004 Aug; 151(2):388-96. PubMed ID: 15327546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria.
    Hide M; Francis DM; Grattan CE; Hakimi J; Kochan JP; Greaves MW
    N Engl J Med; 1993 Jun; 328(22):1599-604. PubMed ID: 7683772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli.
    Luquin E; Kaplan AP; Ferrer M
    Clin Exp Allergy; 2005 Apr; 35(4):456-60. PubMed ID: 15836753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In chronic idiopathic urticaria autoantibodies against Fc epsilonRII/CD23 induce histamine release via eosinophil activation.
    Puccetti A; Bason C; Simeoni S; Millo E; Tinazzi E; Beri R; Peterlana D; Zanoni G; Senna G; Corrocher R; Lunardi C
    Clin Exp Allergy; 2005 Dec; 35(12):1599-607. PubMed ID: 16393326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic urticaria sera increase basophil CD203c expression.
    Yasnowsky KM; Dreskin SC; Efaw B; Schoen D; Vedanthan PK; Alam R; Harbeck RJ
    J Allergy Clin Immunol; 2006 Jun; 117(6):1430-4. PubMed ID: 16751009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients?
    Fiebiger E; Maurer D; Holub H; Reininger B; Hartmann G; Woisetschläger M; Kinet JP; Stingl G
    J Clin Invest; 1995 Dec; 96(6):2606-12. PubMed ID: 8675625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of basophil-activating IgG autoantibodies in chronic idiopathic urticaria by induction of CD 63.
    De Swerdt A; Van Den Keybus C; Kasran A; Cadot P; Neyens K; Coorevits L; Kochuyt AM; Degreef H; Ceuppens JL
    J Allergy Clin Immunol; 2005 Sep; 116(3):662-7. PubMed ID: 16159640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of basophil histamine release against the autologous serum skin test and outcome of serum-induced basophil histamine release studies in a large population of chronic urticaria patients.
    Platzer MH; Grattan CE; Poulsen LK; Skov PS
    Allergy; 2005 Sep; 60(9):1152-6. PubMed ID: 16076300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant correlation between the CD63 assay and the histamine release assay in chronic urticaria.
    Szegedi A; Irinyi B; Gál M; Hunyadi J; Dankó K; Kiss E; Sipka S; Szegedi G; Gyimesi E
    Br J Dermatol; 2006 Jul; 155(1):67-75. PubMed ID: 16792754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-human IgG causes basophil histamine release by acting on IgG-IgE complexes bound to IgE receptors.
    Lichtenstein LM; Kagey-Sobotka A; White JM; Hamilton RG
    J Immunol; 1992 Jun; 148(12):3929-36. PubMed ID: 1376345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic autoimmune urticaria with omalizumab.
    Kaplan AP; Joseph K; Maykut RJ; Geba GP; Zeldin RK
    J Allergy Clin Immunol; 2008 Sep; 122(3):569-73. PubMed ID: 18774392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression--inhibitory effects ofanti-inflammatory drugs.
    Wedi B; Novacovic V; Koerner M; Kapp A
    J Allergy Clin Immunol; 2000 Mar; 105(3):552-60. PubMed ID: 10719307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of chronic urticaria.
    Kaplan AP; Greaves M
    Clin Exp Allergy; 2009 Jun; 39(6):777-87. PubMed ID: 19400905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria.
    Ferrer M; Kinét JP; Kaplan AP
    J Allergy Clin Immunol; 1998 May; 101(5):672-6. PubMed ID: 9600505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of autoimmunity in patients with chronic urticaria.
    Tong LJ; Balakrishnan G; Kochan JP; Kinét JP; Kaplan AP
    J Allergy Clin Immunol; 1997 Apr; 99(4):461-5. PubMed ID: 9111489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the in vivo autologous skin test with in vitro diagnostic tests for diagnosis of chronic autoimmune urticaria.
    Altrich ML; Halsey JF; Altman LC
    Allergy Asthma Proc; 2009; 30(1):28-34. PubMed ID: 19026096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship.
    Fiebiger E; Hammerschmid F; Stingl G; Maurer D
    J Clin Invest; 1998 Jan; 101(1):243-51. PubMed ID: 9421487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria.
    Konstantinou GN; Asero R; Ferrer M; Knol EF; Maurer M; Raap U; Schmid-Grendelmeier P; Skov PS; Grattan CE
    Allergy; 2013 Jan; 68(1):27-36. PubMed ID: 23157716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.